Skip to main content
Cytogen, Inc. logo

Cytogen, Inc. — Investor Relations & Filings

Ticker · 217330 ISIN · KR7217330000 KO Manufacturing
Open in API
Filings indexed 437 across all filing types
Latest filing 2020-09-03 Director's Dealing
Country KR South Korea
Listing KO 217330

About Cytogen, Inc.

https://www.cytogenlab.com/

Cytogen, Inc. is a biotechnology company specializing in liquid biopsy platforms for precision oncology. The company has developed proprietary technology for the rapid isolation and analysis of viable Circulating Tumor Cells (CTCs) from whole blood. Its core offering, the SmartBiopsy Platform, utilizes a high-density microporous chip with microfluidics and nanotechnology to capture CTCs efficiently. This non-invasive diagnostic approach is designed to support early cancer detection, treatment monitoring, and the advancement of personalized medicine for cancer patients.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form required by the Financial Supervisory Service (FSS) in South Korea when a company insider (director or major shareholder) changes their shareholding position. This falls under the category of 'Director's Dealing' (DIRS) as it reports personal share transactions by a company executive.
2020-09-03 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and special related parties (insider transactions/shareholding changes). This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2020-09-03 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically identifies itself as a '정정신고' (Correction Report) regarding a previously submitted stock option grant. This document details changes to the number of shares granted and the list of recipients due to employee departures. Since it is a regulatory filing regarding capital structure and employee compensation (stock options) that does not fit into specific categories like 'Director's Dealing' or 'Share Issue', it is classified as a general regulatory filing.
2020-08-19 Korean
반기보고서 (2020.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for the company 'Cytogen' covering the period from January 1, 2020, to June 30, 2020. It contains detailed financial and business information, including company history, management changes, capital structure, and business operations. This fits the definition of an Interim/Quarterly Report (IR) as it provides comprehensive financial and operational data for a period shorter than a full fiscal year. H1 2020
2020-08-14 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from the Korean DART system regarding a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결) and its subsequent amendment (정정신고). It details a specific business contract for mask manufacturing equipment. Since this is a specific regulatory disclosure of a material business event that does not fit into categories like financial reports, dividends, or board changes, it is classified as a general regulatory filing.
2020-07-30 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Financial Investment Services and Capital Markets Act. This document details changes in share ownership by major shareholders and special related parties (insiders). In the context of the provided filing categories, this falls under 'Major Shareholding Notification' (MRQ), as it specifically tracks the acquisition or disposal of shares that cross reporting thresholds.
2020-07-27 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.